Biogen Inc (BIIB.O)

BIIB.O on Nasdaq

387.48USD
3 Jun 2015
Change (% chg)

$-0.14 (-0.04%)
Prev Close
$387.62
Open
$388.77
Day's High
$393.79
Day's Low
$387.33
Volume
1,281,424
Avg. Vol
1,998,804
52-wk High
$480.18
52-wk Low
$290.85

BIIB.O

Chart for BIIB.O

About

Biogen Inc., formerly Biogen Idec Inc., is a global biotechnology company. The Company discovers, develops, manufactures and markets therapies for the treatment of neurodegenerative diseases, hemophilia and autoimmune disorders. The Company’s products include AVONEX, TYSABRI, FAMPYRA, FUMADERM and RITUXAN. AVONEX is prescribed... (more)

Overall

Beta: 1.02
Market Cap(Mil.): $91,179.66
Shares Outstanding(Mil.): 235.23
Dividend: --
Yield (%): --

Financials

  BIIB.O Industry Sector
P/E (TTM): 27.98 36.69 38.84
EPS (TTM): 13.85 -- --
ROI: 27.53 17.28 16.53
ROE: 31.51 18.14 17.62
Search Stocks

US STOCKS-Nasdaq hits 15-year high, propelled by Amazon, Microsoft

* Amazon shares touch life high after revenue beats estimates

24 Apr 2015

Biogen says Tecfidera sales slow, delays data readout on Alzheimer's drug

- Slowing sales of Biogen Inc's key oral multiple sclerosis (MS) drug Tecfidera and a delay in a data readout for its keenly watched Alzheimer's drug sent the company's stock down as much as 8 percent on Friday.

24 Apr 2015

UPDATE 3-Biogen says Tecfidera sales slow, delays data readout on Alzheimer's drug

* Co delays key data readout - executives (Adds company, analyst comments on Alzheimer's drug data; Updates shares)

24 Apr 2015

US STOCKS-Nasdaq hits 15-year high, propelled by Amazon, Microsoft

* Amazon shares touch life high after revenue beats estimates

24 Apr 2015

Biogen 1st qtr profit jumps 71 pct as MS drug Tecfidera shines

April 24 - Biogen Inc reported a 71 percent rise in quarterly profit, driven by strong demand for its top-selling oral multiple sclerosis (MS) drug, Tecfidera.

24 Apr 2015

Exclusive: Biogen shortens name, expands ambitions in Alzheimer's, ALS

NEW YORK - Biogen Idec Inc has seen its market value quadruple in three years to more than $100 billion on the back of its successful multiple sclerosis drugs. Now it has new ambitions in its sights. | Video

23 Mar 2015

Biogen's Alzheimer's drug slows mental decline in early study

- An experimental drug from Biogen Idec Inc became the first Alzheimer's treatment to significantly slow cognitive decline and reduce what is believed to be brain-destroying plaque in patients with early and mild forms of the disease, according to a small study likely to reignite hopes of a treatment. | Video

20 Mar 2015

UPDATE 1-Biogen's Alzheimer's drug slows mental decline in early study

March 20 - An experimental drug from Biogen Idec Inc became the first Alzheimer's treatment to significantly slow cognitive decline and reduce what is believed to be brain-destroying plaque in patients with early and mild forms of the disease, according to a small study likely to reignite hopes of a treatment.

20 Mar 2015

US STOCKS-Wall St set for higher open as Nike provides lift

* Futures up: Dow 148 pts, S&P 15 pts, Nasdaq 36 pts (Adds quote, updates prices)

20 Mar 2015

UPDATE 1-Dementia drug research aided by $100 mln venture capital fund

* Backers include British govt, GSK, J&J, Pfizer, Lilly, Biogen

17 Mar 2015

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $100.09 +0.11
Pfizer Inc. (PFE.N) $34.41 -0.08
Novartis AG (NOVN.VX) CHF97.00 +0.70
Merck & Co., Inc. (MRK.N) $60.39 +0.15
Roche Holding Ltd. (ROG.VX) CHF276.70 +1.40
Bayer AG (BAYGn.DE) €129.50 +0.75
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €91.12 +1.48
GlaxoSmithKline plc (GSK.L) 1,437.50p -3.50
Teva Pharmaceutical Industries Limited (TEVA.TA) 23,280.00₪ +190.00

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks